long-term disease control in advanced renal cell cancer with brain metastases with pazopanib (case report and literature review)
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

long-term disease control in advanced renal cell cancer with brain metastases with pazopanib (case report and literature review)

;V. V. Chernova;L. N. Volodina;A. V. Grigoriev;A. I. Smirnov;E. V. Shustova;O. P. Zhuravlеva;M. P. Bublikova;V. V. Vizhgorodskaya;M. V. Shomovа;M. G. Matyash
supportive care in cancer 2015 Vol. 11 pp. 96-100
219
chernova2015onkourologilong-term

Abstract

We report the case of advanced clear cell renal cell carcinoma with brain, pulmonary, hepatic and bone metastases treated with pazopanib.We observed the complete response in brain metastases and stable extracranial disease after 4 years of the treatment. According to the literature review this is the first reported case of complete response to pazopanib in brain metastases in renal cell carcinoma.

Keywords

tyrosine kinase inhibitors bone metastases

Access

DOI:
10.17650/1726-9776-2015-11-3-96-100
URL:
https://oncourology.abvpress.ru/oncur/article/view...

Citation

ID: 161352
Ref Key: chernova2015onkourologilong-term
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
161352
Unique Identifier:
10.17650/1726-9776-2015-11-3-96-100
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store